Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/17/21
06/17
04:55
06/17/21
04:55
APTO

Aptose Biosciences

$3.39 /

-0.115 (-3.29%)

, MBIO

Mustang Bio

$3.48 /

-0.09 (-2.52%)

, QURE

uniQure

$34.41 /

-0.015 (-0.04%)

, RIGL

Rigel Pharmaceuticals

$4.20 /

-0.07 (-1.64%)

, MGTA

Magenta Therapeutics

$11.13 /

-0.2 (-1.77%)

, MEIP

MEI Pharma

$3.32 /

+0.22 (+7.10%)

, CRIS

Curis

$7.58 /

-0.07 (-0.92%)

, XLRN

Acceleron

$126.85 /

-1.78 (-1.38%)

, EPZM

Epizyme

$8.81 /

+0.025 (+0.28%)

, INCY

Incyte

$83.13 /

+0.44 (+0.53%)

, ORTX

Orchard Therapeutics

$4.79 /

-0.06 (-1.24%)

, TGTX

TG Therapeutics

$36.64 /

-0.8 (-2.14%)

, EQ

Equillium

$5.87 /

-0.17 (-2.81%)

, JAZZ

Jazz Pharmaceuticals

$181.08 /

-2.19 (-1.19%)

, VRTX

Vertex Pharmaceuticals

$187.51 /

-1.43 (-0.76%)

, SGEN

Seagen

$151.42 /

-1.93 (-1.26%)

, IMRA

Imara

$7.76 /

-0.5 (-6.05%)

, GBT

Global Blood Therapeutics

$38.21 /

-1.39 (-3.51%)

, BGNE

BeiGene

$333.73 /

+2.27 (+0.68%)

, APLS

Apellis

$59.71 /

-0.97 (-1.60%)

, AGIO

Agios Pharmaceuticals

$58.82 /

+0.63 (+1.08%)

, FMTX

Forma Therapeutics

$24.23 /

+0.1 (+0.41%)

, KROS

Keros Therapeutics

$52.91 /

+0.32 (+0.61%)

, CYAD

Celyad

$5.33 /

-0.11 (-2.02%)

, ALXN

Alexion

$180.56 /

-1.34 (-0.74%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$126.85 /

-1.78 (-1.38%)

VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

TGTX TG Therapeutics
$36.64 /

-0.8 (-2.14%)

SGEN Seagen
$151.42 /

-1.93 (-1.26%)

RIGL Rigel Pharmaceuticals
$4.20 /

-0.07 (-1.64%)

QURE uniQure
$34.41 /

-0.015 (-0.04%)

ORTX Orchard Therapeutics
$4.79 /

-0.06 (-1.24%)

MGTA Magenta Therapeutics
$11.13 /

-0.2 (-1.77%)

MEIP MEI Pharma
$3.32 /

+0.22 (+7.10%)

MBIO Mustang Bio
$3.48 /

-0.09 (-2.52%)

KROS Keros Therapeutics
$52.91 /

+0.32 (+0.61%)

JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

IMRA Imara
$7.76 /

-0.5 (-6.05%)

GBT Global Blood Therapeutics
$38.21 /

-1.39 (-3.51%)

FMTX Forma Therapeutics
$24.23 /

+0.1 (+0.41%)

EQ Equillium
$5.87 /

-0.17 (-2.81%)

EPZM Epizyme
$8.81 /

+0.025 (+0.28%)

CYAD Celyad
$5.33 /

-0.11 (-2.02%)

CRIS Curis
$7.58 /

-0.07 (-0.92%)

BGNE BeiGene
$333.73 /

+2.27 (+0.68%)

APTO Aptose Biosciences
$3.39 /

-0.115 (-3.29%)

APLS Apellis
$59.71 /

-0.97 (-1.60%)

ALXN Alexion
$180.56 /

-1.34 (-0.74%)

AGIO Agios Pharmaceuticals
$58.82 /

+0.63 (+1.08%)

APTO Aptose Biosciences
$3.39 /

-0.115 (-3.29%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.48 /

-0.09 (-2.52%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$34.41 /

-0.015 (-0.04%)

06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
06/14/21 BTIG
uniQure initiated with a Buy at BTIG
05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
RIGL Rigel Pharmaceuticals
$4.20 /

-0.07 (-1.64%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.13 /

-0.2 (-1.77%)

06/14/21 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
MEIP MEI Pharma
$3.32 /

+0.22 (+7.10%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$7.58 /

-0.07 (-0.92%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$126.85 /

-1.78 (-1.38%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.81 /

+0.025 (+0.28%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$83.13 /

+0.44 (+0.53%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$4.79 /

-0.06 (-1.24%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$36.64 /

-0.8 (-2.14%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$5.87 /

-0.17 (-2.81%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
SGEN Seagen
$151.42 /

-1.93 (-1.26%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$7.76 /

-0.5 (-6.05%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$38.21 /

-1.39 (-3.51%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$333.73 /

+2.27 (+0.68%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
APLS Apellis
$59.71 /

-0.97 (-1.60%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$58.82 /

+0.63 (+1.08%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$24.23 /

+0.1 (+0.41%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$52.91 /

+0.32 (+0.61%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.33 /

-0.11 (-2.02%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$180.56 /

-1.34 (-0.74%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$126.85 /

-1.78 (-1.38%)

VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

TGTX TG Therapeutics
$36.64 /

-0.8 (-2.14%)

SGEN Seagen
$151.42 /

-1.93 (-1.26%)

RIGL Rigel Pharmaceuticals
$4.20 /

-0.07 (-1.64%)

QURE uniQure
$34.41 /

-0.015 (-0.04%)

ORTX Orchard Therapeutics
$4.79 /

-0.06 (-1.24%)

MGTA Magenta Therapeutics
$11.13 /

-0.2 (-1.77%)

MEIP MEI Pharma
$3.32 /

+0.22 (+7.10%)

MBIO Mustang Bio
$3.48 /

-0.09 (-2.52%)

KROS Keros Therapeutics
$52.91 /

+0.32 (+0.61%)

JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

IMRA Imara
$7.76 /

-0.5 (-6.05%)

GBT Global Blood Therapeutics
$38.21 /

-1.39 (-3.51%)

FMTX Forma Therapeutics
$24.23 /

+0.1 (+0.41%)

EQ Equillium
$5.87 /

-0.17 (-2.81%)

EPZM Epizyme
$8.81 /

+0.025 (+0.28%)

CRIS Curis
$7.58 /

-0.07 (-0.92%)

BGNE BeiGene
$333.73 /

+2.27 (+0.68%)

APTO Aptose Biosciences
$3.39 /

-0.115 (-3.29%)

APLS Apellis
$59.71 /

-0.97 (-1.60%)

ALXN Alexion
$180.56 /

-1.34 (-0.74%)

AGIO Agios Pharmaceuticals
$58.82 /

+0.63 (+1.08%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

RIGL Rigel Pharmaceuticals
$4.20 /

-0.07 (-1.64%)

ORTX Orchard Therapeutics
$4.79 /

-0.06 (-1.24%)

JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

EPZM Epizyme
$8.81 /

+0.025 (+0.28%)

VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

TGTX TG Therapeutics
$36.64 /

-0.8 (-2.14%)

SGEN Seagen
$151.42 /

-1.93 (-1.26%)

QURE uniQure
$34.41 /

-0.015 (-0.04%)

MBIO Mustang Bio
$3.48 /

-0.09 (-2.52%)

JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

IMRA Imara
$7.76 /

-0.5 (-6.05%)

GBT Global Blood Therapeutics
$38.21 /

-1.39 (-3.51%)

EQ Equillium
$5.87 /

-0.17 (-2.81%)

CRIS Curis
$7.58 /

-0.07 (-0.92%)

APTO Aptose Biosciences
$3.39 /

-0.115 (-3.29%)

APLS Apellis
$59.71 /

-0.97 (-1.60%)

ALXN Alexion
$180.56 /

-1.34 (-0.74%)

VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

FMTX Forma Therapeutics
$24.23 /

+0.1 (+0.41%)

EQ Equillium
$5.87 /

-0.17 (-2.81%)

CRIS Curis
$7.58 /

-0.07 (-0.92%)

APLS Apellis
$59.71 /

-0.97 (-1.60%)

ALXN Alexion
$180.56 /

-1.34 (-0.74%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/16/21
06/16
04:55
06/16/21
04:55
APTO

Aptose Biosciences

$3.50 /

-0.21 (-5.66%)

, MBIO

Mustang Bio

$3.57 /

-0.115 (-3.13%)

, QURE

uniQure

$34.46 /

-0.43 (-1.23%)

, RIGL

Rigel Pharmaceuticals

$4.27 /

-0.1 (-2.29%)

, MGTA

Magenta Therapeutics

$11.38 /

+0.05 (+0.44%)

, MEIP

MEI Pharma

$3.10 /

-0.15 (-4.62%)

, CRIS

Curis

$7.61 /

-0.44 (-5.47%)

, XLRN

Acceleron

$128.63 /

-2.39 (-1.82%)

, EPZM

Epizyme

$8.79 /

-0.025 (-0.28%)

, INCY

Incyte

$82.69 /

+0.11 (+0.13%)

, ORTX

Orchard Therapeutics

$4.85 /

-0.19 (-3.77%)

, TGTX

TG Therapeutics

$37.42 /

-0.88 (-2.30%)

, EQ

Equillium

$6.05 /

+0.05 (+0.83%)

, JAZZ

Jazz Pharmaceuticals

$183.42 /

-2.7 (-1.45%)

, VRTX

Vertex Pharmaceuticals

$188.94 /

-5.87 (-3.01%)

, SGEN

Seagen

$153.20 /

-2.99 (-1.91%)

, IMRA

Imara

$8.26 /

-0.44 (-5.06%)

, GBT

Global Blood Therapeutics

$39.60 /

-0.65 (-1.61%)

, BGNE

BeiGene

$332.97 /

-9.75 (-2.84%)

, APLS

Apellis

$60.63 /

-4.27 (-6.58%)

, AGIO

Agios Pharmaceuticals

$58.23 /

+0.04 (+0.07%)

, FMTX

Forma Therapeutics

$24.13 /

-0.09 (-0.37%)

, KROS

Keros Therapeutics

$52.55 /

-0.455 (-0.86%)

, CYAD

Celyad

$5.44 /

+0.03 (+0.55%)

, ALXN

Alexion

$181.90 /

+0.25 (+0.14%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$128.63 /

-2.39 (-1.82%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

SGEN Seagen
$153.20 /

-2.99 (-1.91%)

RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

QURE uniQure
$34.46 /

-0.43 (-1.23%)

ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

MGTA Magenta Therapeutics
$11.38 /

+0.05 (+0.44%)

MEIP MEI Pharma
$3.10 /

-0.15 (-4.62%)

MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

KROS Keros Therapeutics
$52.55 /

-0.455 (-0.86%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

IMRA Imara
$8.26 /

-0.44 (-5.06%)

GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

CYAD Celyad
$5.44 /

+0.03 (+0.55%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

BGNE BeiGene
$332.97 /

-9.75 (-2.84%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

AGIO Agios Pharmaceuticals
$58.23 /

+0.04 (+0.07%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$34.46 /

-0.43 (-1.23%)

06/14/21 BTIG
uniQure initiated with a Buy at BTIG
05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.38 /

+0.05 (+0.44%)

06/14/21 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
MEIP MEI Pharma
$3.10 /

-0.15 (-4.62%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$7.61 /

-0.44 (-5.47%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$128.63 /

-2.39 (-1.82%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.69 /

+0.11 (+0.13%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.05 /

+0.05 (+0.83%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
SGEN Seagen
$153.20 /

-2.99 (-1.91%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.26 /

-0.44 (-5.06%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$332.97 /

-9.75 (-2.84%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
APLS Apellis
$60.63 /

-4.27 (-6.58%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$58.23 /

+0.04 (+0.07%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$52.55 /

-0.455 (-0.86%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.44 /

+0.03 (+0.55%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.90 /

+0.25 (+0.14%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$128.63 /

-2.39 (-1.82%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

SGEN Seagen
$153.20 /

-2.99 (-1.91%)

RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

QURE uniQure
$34.46 /

-0.43 (-1.23%)

ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

MGTA Magenta Therapeutics
$11.38 /

+0.05 (+0.44%)

MEIP MEI Pharma
$3.10 /

-0.15 (-4.62%)

MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

KROS Keros Therapeutics
$52.55 /

-0.455 (-0.86%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

IMRA Imara
$8.26 /

-0.44 (-5.06%)

GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

BGNE BeiGene
$332.97 /

-9.75 (-2.84%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

AGIO Agios Pharmaceuticals
$58.23 /

+0.04 (+0.07%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

SGEN Seagen
$153.20 /

-2.99 (-1.91%)

QURE uniQure
$34.46 /

-0.43 (-1.23%)

MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

IMRA Imara
$8.26 /

-0.44 (-5.06%)

GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
APTO

Aptose Biosciences

$3.71 /

-0.04 (-1.07%)

, MBIO

Mustang Bio

$3.68 /

-0.11 (-2.90%)

, QURE

uniQure

$34.89 /

-1.24 (-3.43%)

, RIGL

Rigel Pharmaceuticals

$4.37 /

+0.35 (+8.71%)

, MGTA

Magenta Therapeutics

$11.33 /

-0.22 (-1.90%)

, MEIP

MEI Pharma

$3.28 /

+0.005 (+0.15%)

, CRIS

Curis

$8.05 /

+0.05 (+0.63%)

, XLRN

Acceleron

$131.02 /

-2.4 (-1.80%)

, EPZM

Epizyme

$8.81 /

+0.305 (+3.59%)

, INCY

Incyte

$82.61 /

+0.03 (+0.04%)

, ORTX

Orchard Therapeutics

$5.04 /

-0.09 (-1.75%)

, TGTX

TG Therapeutics

$38.30 /

+0.49 (+1.30%)

, EQ

Equillium

$6.00 /

-0.12 (-1.96%)

, JAZZ

Jazz Pharmaceuticals

$186.45 /

+0.15 (+0.08%)

, VRTX

Vertex Pharmaceuticals

$194.81 /

+1.78 (+0.92%)

, SGEN

Seagen

$156.25 /

-0.21 (-0.13%)

, IMRA

Imara

$8.70 /

+0.135 (+1.58%)

, GBT

Global Blood Therapeutics

$40.25 /

-0.32 (-0.79%)

, BGNE

BeiGene

$344.52 /

-5.39 (-1.54%)

, APLS

Apellis

$64.90 /

+2.8 (+4.51%)

, AGIO

Agios Pharmaceuticals

$58.20 /

+0.43 (+0.74%)

, FMTX

Forma Therapeutics

$24.22 /

+1.41 (+6.18%)

, KROS

Keros Therapeutics

$53.00 /

+1.64 (+3.19%)

, CYAD

Celyad

$5.41 /

-0.29 (-5.09%)

, ALXN

Alexion

$181.65 /

+0.08 (+0.04%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$131.02 /

-2.4 (-1.80%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

SGEN Seagen
$156.25 /

-0.21 (-0.13%)

RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

QURE uniQure
$34.89 /

-1.24 (-3.43%)

ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

MGTA Magenta Therapeutics
$11.33 /

-0.22 (-1.90%)

MEIP MEI Pharma
$3.28 /

+0.005 (+0.15%)

MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

KROS Keros Therapeutics
$53.00 /

+1.64 (+3.19%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

IMRA Imara
$8.70 /

+0.135 (+1.58%)

GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

CYAD Celyad
$5.41 /

-0.29 (-5.09%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

BGNE BeiGene
$344.52 /

-5.39 (-1.54%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

AGIO Agios Pharmaceuticals
$58.20 /

+0.43 (+0.74%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$34.89 /

-1.24 (-3.43%)

06/14/21 BTIG
uniQure initiated with a Buy at BTIG
05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.33 /

-0.22 (-1.90%)

06/14/21 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
MEIP MEI Pharma
$3.28 /

+0.005 (+0.15%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.05 /

+0.05 (+0.63%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$131.02 /

-2.4 (-1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.61 /

+0.03 (+0.04%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.00 /

-0.12 (-1.96%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
SGEN Seagen
$156.25 /

-0.21 (-0.13%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.70 /

+0.135 (+1.58%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$344.52 /

-5.39 (-1.54%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
APLS Apellis
$64.90 /

+2.8 (+4.51%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$58.20 /

+0.43 (+0.74%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$53.00 /

+1.64 (+3.19%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.41 /

-0.29 (-5.09%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.65 /

+0.08 (+0.04%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$131.02 /

-2.4 (-1.80%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

SGEN Seagen
$156.25 /

-0.21 (-0.13%)

RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

QURE uniQure
$34.89 /

-1.24 (-3.43%)

ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

MGTA Magenta Therapeutics
$11.33 /

-0.22 (-1.90%)

MEIP MEI Pharma
$3.28 /

+0.005 (+0.15%)

MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

KROS Keros Therapeutics
$53.00 /

+1.64 (+3.19%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

IMRA Imara
$8.70 /

+0.135 (+1.58%)

GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

BGNE BeiGene
$344.52 /

-5.39 (-1.54%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

AGIO Agios Pharmaceuticals
$58.20 /

+0.43 (+0.74%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

SGEN Seagen
$156.25 /

-0.21 (-0.13%)

QURE uniQure
$34.89 /

-1.24 (-3.43%)

MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

IMRA Imara
$8.70 /

+0.135 (+1.58%)

GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
APTO

Aptose Biosciences

$3.75 /

-1.79 (-32.31%)

, MBIO

Mustang Bio

$3.79 /

-0.03 (-0.79%)

, QURE

uniQure

$36.05 /

-0.63 (-1.72%)

, RIGL

Rigel Pharmaceuticals

$4.02 /

-0.16 (-3.83%)

, MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, MEIP

MEI Pharma

$3.28 /

+0.08 (+2.50%)

, CRIS

Curis

$8.00 /

-4.72 (-37.11%)

, XLRN

Acceleron

$133.36 /

+2.36 (+1.80%)

, EPZM

Epizyme

$8.53 /

+0.08 (+0.95%)

, INCY

Incyte

$82.59 /

-4.97 (-5.68%)

, ORTX

Orchard Therapeutics

$5.12 /

-0.05 (-0.97%)

, TGTX

TG Therapeutics

$37.81 /

-0.14 (-0.37%)

, EQ

Equillium

$6.12 /

-0.85 (-12.20%)

, JAZZ

Jazz Pharmaceuticals

$186.19 /

-0.21 (-0.11%)

, VRTX

Vertex Pharmaceuticals

$193.02 /

-23.93 (-11.03%)

, SGEN

Seagen

$156.27 /

-2.3 (-1.45%)

, IMRA

Imara

$8.56 /

-0.235 (-2.67%)

, GBT

Global Blood Therapeutics

$40.64 /

-1.01 (-2.42%)

, BGNE

BeiGene

$346.81 /

-6.09 (-1.73%)

, APLS

Apellis

$62.10 /

+1.33 (+2.19%)

, AGIO

Agios Pharmaceuticals

$57.80 /

-1.69 (-2.84%)

, FMTX

Forma Therapeutics

$22.81 /

-5.2 (-18.56%)

, KROS

Keros Therapeutics

$51.75 /

-0.61 (-1.17%)

, CYAD

Celyad

$5.75 /

-0.22 (-3.69%)

, ALXN

Alexion

$181.64 /

-0.41 (-0.23%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CYAD Celyad
$5.75 /

-0.22 (-3.69%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.05 /

-0.63 (-1.72%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.00 /

-4.72 (-37.11%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.59 /

-4.97 (-5.68%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.12 /

-0.85 (-12.20%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Stifel
Vertex shares look 'cheap' at aftermarket levels, says Stifel
SGEN Seagen
$156.27 /

-2.3 (-1.45%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.56 /

-0.235 (-2.67%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$62.10 /

+1.33 (+2.19%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.75 /

-0.22 (-3.69%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.64 /

-0.41 (-0.23%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/13/21
06/13
04:55
06/13/21
04:55
APTO

Aptose Biosciences

$3.75 /

-1.79 (-32.31%)

, MBIO

Mustang Bio

$3.79 /

-0.03 (-0.79%)

, QURE

uniQure

$36.05 /

-0.63 (-1.72%)

, RIGL

Rigel Pharmaceuticals

$4.02 /

-0.16 (-3.83%)

, MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, MEIP

MEI Pharma

$3.28 /

+0.08 (+2.50%)

, CRIS

Curis

$8.00 /

-4.72 (-37.11%)

, XLRN

Acceleron

$133.36 /

+2.36 (+1.80%)

, EPZM

Epizyme

$8.53 /

+0.08 (+0.95%)

, INCY

Incyte

$82.59 /

-4.97 (-5.68%)

, ORTX

Orchard Therapeutics

$5.12 /

-0.05 (-0.97%)

, TGTX

TG Therapeutics

$37.81 /

-0.14 (-0.37%)

, EQ

Equillium

$6.12 /

-0.85 (-12.20%)

, JAZZ

Jazz Pharmaceuticals

$186.19 /

-0.21 (-0.11%)

, VRTX

Vertex Pharmaceuticals

$193.02 /

-23.93 (-11.03%)

, SGEN

Seagen

$156.27 /

-2.3 (-1.45%)

, IMRA

Imara

$8.56 /

-0.235 (-2.67%)

, GBT

Global Blood Therapeutics

$40.64 /

-1.01 (-2.42%)

, BGNE

BeiGene

$346.81 /

-6.09 (-1.73%)

, APLS

Apellis

$62.10 /

+1.33 (+2.19%)

, AGIO

Agios Pharmaceuticals

$57.80 /

-1.69 (-2.84%)

, FMTX

Forma Therapeutics

$22.81 /

-5.2 (-18.56%)

, KROS

Keros Therapeutics

$51.75 /

-0.61 (-1.17%)

, CYAD

Celyad

$5.75 /

-0.22 (-3.69%)

, ALXN

Alexion

$181.64 /

-0.41 (-0.23%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CYAD Celyad
$5.75 /

-0.22 (-3.69%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.05 /

-0.63 (-1.72%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.00 /

-4.72 (-37.11%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.59 /

-4.97 (-5.68%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.12 /

-0.85 (-12.20%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Stifel
Vertex shares look 'cheap' at aftermarket levels, says Stifel
06/11/21 Cantor Fitzgerald
Vertex Pharmaceuticals price target lowered to $281 from $285 at Cantor Fitzgerald
SGEN Seagen
$156.27 /

-2.3 (-1.45%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.56 /

-0.235 (-2.67%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$62.10 /

+1.33 (+2.19%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.75 /

-0.22 (-3.69%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.64 /

-0.41 (-0.23%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/12/21
06/12
04:55
06/12/21
04:55
APTO

Aptose Biosciences

$3.75 /

-1.79 (-32.31%)

, MBIO

Mustang Bio

$3.79 /

-0.03 (-0.79%)

, QURE

uniQure

$36.05 /

-0.63 (-1.72%)

, RIGL

Rigel Pharmaceuticals

$4.02 /

-0.16 (-3.83%)

, MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, MEIP

MEI Pharma

$3.28 /

+0.08 (+2.50%)

, CRIS

Curis

$8.00 /

-4.72 (-37.11%)

, XLRN

Acceleron

$133.36 /

+2.36 (+1.80%)

, EPZM

Epizyme

$8.53 /

+0.08 (+0.95%)

, INCY

Incyte

$82.59 /

-4.97 (-5.68%)

, ORTX

Orchard Therapeutics

$5.12 /

-0.05 (-0.97%)

, TGTX

TG Therapeutics

$37.81 /

-0.14 (-0.37%)

, EQ

Equillium

$6.12 /

-0.85 (-12.20%)

, JAZZ

Jazz Pharmaceuticals

$186.19 /

-0.21 (-0.11%)

, VRTX

Vertex Pharmaceuticals

$193.02 /

-23.93 (-11.03%)

, SGEN

Seagen

$156.27 /

-2.3 (-1.45%)

, IMRA

Imara

$8.56 /

-0.235 (-2.67%)

, GBT

Global Blood Therapeutics

$40.64 /

-1.01 (-2.42%)

, BGNE

BeiGene

$346.81 /

-6.09 (-1.73%)

, APLS

Apellis

$62.10 /

+1.33 (+2.19%)

, AGIO

Agios Pharmaceuticals

$57.80 /

-1.69 (-2.84%)

, FMTX

Forma Therapeutics

$22.81 /

-5.2 (-18.56%)

, KROS

Keros Therapeutics

$51.75 /

-0.61 (-1.17%)

, CYAD

Celyad

$5.75 /

-0.22 (-3.69%)

, ALXN

Alexion

$181.64 /

-0.41 (-0.23%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CYAD Celyad
$5.75 /

-0.22 (-3.69%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.05 /

-0.63 (-1.72%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.00 /

-4.72 (-37.11%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.59 /

-4.97 (-5.68%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.12 /

-0.85 (-12.20%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Stifel
Vertex shares look 'cheap' at aftermarket levels, says Stifel
06/11/21 Cantor Fitzgerald
Vertex Pharmaceuticals price target lowered to $281 from $285 at Cantor Fitzgerald
SGEN Seagen
$156.27 /

-2.3 (-1.45%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.56 /

-0.235 (-2.67%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$62.10 /

+1.33 (+2.19%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.75 /

-0.22 (-3.69%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.64 /

-0.41 (-0.23%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/11/21
06/11
04:55
06/11/21
04:55
APTO

Aptose Biosciences

$5.54 /

+0.19 (+3.55%)

, MBIO

Mustang Bio

$3.82 /

+0.07 (+1.87%)

, QURE

uniQure

$36.68 /

+0.3 (+0.82%)

, RIGL

Rigel Pharmaceuticals

$4.18 /

+0.09 (+2.20%)

, MGTA

Magenta Therapeutics

$11.71 /

+0.04 (+0.34%)

, MEIP

MEI Pharma

$3.20 /

+0.045 (+1.43%)

, CRIS

Curis

$12.71 /

-0.3 (-2.31%)

, XLRN

Acceleron

$130.95 /

+4.43 (+3.50%)

, EPZM

Epizyme

$8.46 /

-0.015 (-0.18%)

, INCY

Incyte

$87.53 /

+1.3 (+1.51%)

, ORTX

Orchard Therapeutics

$5.17 /

-0.07 (-1.34%)

, TGTX

TG Therapeutics

$37.93 /

+0.63 (+1.69%)

, EQ

Equillium

$6.97 /

-0.2 (-2.79%)

, JAZZ

Jazz Pharmaceuticals

$186.01 /

+4.16 (+2.29%)

, VRTX

Vertex Pharmaceuticals

$216.92 /

+3.43 (+1.61%)

, SGEN

Seagen

$158.57 /

+2.92 (+1.88%)

, IMRA

Imara

$8.79 /

+0.06 (+0.69%)

, GBT

Global Blood Therapeutics

$41.66 /

+1.235 (+3.06%)

, BGNE

BeiGene

$352.81 /

+7.16 (+2.07%)

, APLS

Apellis

$60.92 /

+2.04 (+3.46%)

, AGIO

Agios Pharmaceuticals

$59.49 /

+0.46 (+0.78%)

, FMTX

Forma Therapeutics

$28.00 /

-1.21 (-4.14%)

, KROS

Keros Therapeutics

$52.40 /

+0.21 (+0.40%)

, CYAD

Celyad

$5.99 /

+ (+0.00%)

, ALXN

Alexion

$181.95 /

+2.73 (+1.52%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$130.95 /

+4.43 (+3.50%)

VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

SGEN Seagen
$158.57 /

+2.92 (+1.88%)

RIGL Rigel Pharmaceuticals
$4.18 /

+0.09 (+2.20%)

QURE uniQure
$36.68 /

+0.3 (+0.82%)

ORTX Orchard Therapeutics
$5.17 /

-0.07 (-1.34%)

MGTA Magenta Therapeutics
$11.71 /

+0.04 (+0.34%)

MEIP MEI Pharma
$3.20 /

+0.045 (+1.43%)

MBIO Mustang Bio
$3.82 /

+0.07 (+1.87%)

KROS Keros Therapeutics
$52.40 /

+0.21 (+0.40%)

JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

IMRA Imara
$8.79 /

+0.06 (+0.69%)

GBT Global Blood Therapeutics
$41.66 /

+1.235 (+3.06%)

FMTX Forma Therapeutics
$28.00 /

-1.21 (-4.14%)

EQ Equillium
$6.97 /

-0.2 (-2.79%)

EPZM Epizyme
$8.46 /

-0.015 (-0.18%)

CYAD Celyad
$5.99 /

+ (+0.00%)

CRIS Curis
$12.71 /

-0.3 (-2.31%)

BGNE BeiGene
$352.81 /

+7.16 (+2.07%)

APTO Aptose Biosciences
$5.54 /

+0.19 (+3.55%)

APLS Apellis
$60.92 /

+2.04 (+3.46%)

ALXN Alexion
$181.95 /

+2.73 (+1.52%)

AGIO Agios Pharmaceuticals
$59.49 /

+0.46 (+0.78%)

APTO Aptose Biosciences
$5.54 /

+0.19 (+3.55%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.82 /

+0.07 (+1.87%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.68 /

+0.3 (+0.82%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.18 /

+0.09 (+2.20%)

05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
MGTA Magenta Therapeutics
$11.71 /

+0.04 (+0.34%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.20 /

+0.045 (+1.43%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$12.71 /

-0.3 (-2.31%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$130.95 /

+4.43 (+3.50%)

05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
EPZM Epizyme
$8.46 /

-0.015 (-0.18%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$87.53 /

+1.3 (+1.51%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.17 /

-0.07 (-1.34%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.97 /

-0.2 (-2.79%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/20/21 Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
SGEN Seagen
$158.57 /

+2.92 (+1.88%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.79 /

+0.06 (+0.69%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$41.66 /

+1.235 (+3.06%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$352.81 /

+7.16 (+2.07%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$60.92 /

+2.04 (+3.46%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$59.49 /

+0.46 (+0.78%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$28.00 /

-1.21 (-4.14%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$52.40 /

+0.21 (+0.40%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.99 /

+ (+0.00%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.95 /

+2.73 (+1.52%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$130.95 /

+4.43 (+3.50%)

VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

SGEN Seagen
$158.57 /

+2.92 (+1.88%)

RIGL Rigel Pharmaceuticals
$4.18 /

+0.09 (+2.20%)

QURE uniQure
$36.68 /

+0.3 (+0.82%)

ORTX Orchard Therapeutics
$5.17 /

-0.07 (-1.34%)

MGTA Magenta Therapeutics
$11.71 /

+0.04 (+0.34%)

MEIP MEI Pharma
$3.20 /

+0.045 (+1.43%)

MBIO Mustang Bio
$3.82 /

+0.07 (+1.87%)

KROS Keros Therapeutics
$52.40 /

+0.21 (+0.40%)

JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

IMRA Imara
$8.79 /

+0.06 (+0.69%)

GBT Global Blood Therapeutics
$41.66 /

+1.235 (+3.06%)

FMTX Forma Therapeutics
$28.00 /

-1.21 (-4.14%)

EQ Equillium
$6.97 /

-0.2 (-2.79%)

EPZM Epizyme
$8.46 /

-0.015 (-0.18%)

CRIS Curis
$12.71 /

-0.3 (-2.31%)

BGNE BeiGene
$352.81 /

+7.16 (+2.07%)

APTO Aptose Biosciences
$5.54 /

+0.19 (+3.55%)

APLS Apellis
$60.92 /

+2.04 (+3.46%)

ALXN Alexion
$181.95 /

+2.73 (+1.52%)

AGIO Agios Pharmaceuticals
$59.49 /

+0.46 (+0.78%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

RIGL Rigel Pharmaceuticals
$4.18 /

+0.09 (+2.20%)

ORTX Orchard Therapeutics
$5.17 /

-0.07 (-1.34%)

JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

EPZM Epizyme
$8.46 /

-0.015 (-0.18%)

VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

SGEN Seagen
$158.57 /

+2.92 (+1.88%)

QURE uniQure
$36.68 /

+0.3 (+0.82%)

JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

IMRA Imara
$8.79 /

+0.06 (+0.69%)

GBT Global Blood Therapeutics
$41.66 /

+1.235 (+3.06%)

EQ Equillium
$6.97 /

-0.2 (-2.79%)

CRIS Curis
$12.71 /

-0.3 (-2.31%)

APTO Aptose Biosciences
$5.54 /

+0.19 (+3.55%)

APLS Apellis
$60.92 /

+2.04 (+3.46%)

ALXN Alexion
$181.95 /

+2.73 (+1.52%)

VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

FMTX Forma Therapeutics
$28.00 /

-1.21 (-4.14%)

EQ Equillium
$6.97 /

-0.2 (-2.79%)

CRIS Curis
$12.71 /

-0.3 (-2.31%)

APLS Apellis
$60.92 /

+2.04 (+3.46%)

ALXN Alexion
$181.95 /

+2.73 (+1.52%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/10/21
06/10
04:55
06/10/21
04:55
APTO

Aptose Biosciences

$5.35 /

-0.14 (-2.55%)

, MBIO

Mustang Bio

$3.76 /

+0.005 (+0.13%)

, QURE

uniQure

$36.57 /

-0.37 (-1.00%)

, RIGL

Rigel Pharmaceuticals

$4.09 /

+0.11 (+2.76%)

, MGTA

Magenta Therapeutics

$11.67 /

-0.16 (-1.35%)

, MEIP

MEI Pharma

$3.16 /

+0.045 (+1.44%)

, CRIS

Curis

$13.01 /

-1.04 (-7.40%)

, XLRN

Acceleron

$126.52 /

+1.5 (+1.20%)

, EPZM

Epizyme

$8.47 /

+0.1 (+1.19%)

, INCY

Incyte

$86.23 /

+1.45 (+1.71%)

, ORTX

Orchard Therapeutics

$5.24 /

+0.04 (+0.77%)

, TGTX

TG Therapeutics

$37.33 /

+0.17 (+0.46%)

, EQ

Equillium

$7.11 /

-0.48 (-6.32%)

, JAZZ

Jazz Pharmaceuticals

$181.85 /

+2.82 (+1.58%)

, VRTX

Vertex Pharmaceuticals

$213.67 /

+2.57 (+1.22%)

, SGEN

Seagen

$155.59 /

+0.89 (+0.58%)

, IMRA

Imara

$8.83 /

-0.185 (-2.05%)

, GBT

Global Blood Therapeutics

$40.43 /

-0.475 (-1.16%)

, BGNE

BeiGene

$347.81 /

-1.53 (-0.44%)

, APLS

Apellis

$58.87 /

+0.79 (+1.36%)

, AGIO

Agios Pharmaceuticals

$59.04 /

-1.07 (-1.78%)

, FMTX

Forma Therapeutics

$29.18 /

-1.795 (-5.80%)

, KROS

Keros Therapeutics

$51.31 /

-0.36 (-0.70%)

, CYAD

Celyad

$5.99 /

-0.01 (-0.17%)

, ALXN

Alexion

$179.22 /

+2.59 (+1.47%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$126.52 /

+1.5 (+1.20%)

VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

SGEN Seagen
$155.59 /

+0.89 (+0.58%)

RIGL Rigel Pharmaceuticals
$4.09 /

+0.11 (+2.76%)

QURE uniQure
$36.57 /

-0.37 (-1.00%)

ORTX Orchard Therapeutics
$5.24 /

+0.04 (+0.77%)

MGTA Magenta Therapeutics
$11.67 /

-0.16 (-1.35%)

MEIP MEI Pharma
$3.16 /

+0.045 (+1.44%)

MBIO Mustang Bio
$3.76 /

+0.005 (+0.13%)

KROS Keros Therapeutics
$51.31 /

-0.36 (-0.70%)

JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

IMRA Imara
$8.83 /

-0.185 (-2.05%)

GBT Global Blood Therapeutics
$40.43 /

-0.475 (-1.16%)

FMTX Forma Therapeutics
$29.18 /

-1.795 (-5.80%)

EQ Equillium
$7.11 /

-0.48 (-6.32%)

EPZM Epizyme
$8.47 /

+0.1 (+1.19%)

CYAD Celyad
$5.99 /

-0.01 (-0.17%)

CRIS Curis
$13.01 /

-1.04 (-7.40%)

BGNE BeiGene
$347.81 /

-1.53 (-0.44%)

APTO Aptose Biosciences
$5.35 /

-0.14 (-2.55%)

APLS Apellis
$58.87 /

+0.79 (+1.36%)

ALXN Alexion
$179.22 /

+2.59 (+1.47%)

AGIO Agios Pharmaceuticals
$59.04 /

-1.07 (-1.78%)

APTO Aptose Biosciences
$5.35 /

-0.14 (-2.55%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.76 /

+0.005 (+0.13%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.57 /

-0.37 (-1.00%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.09 /

+0.11 (+2.76%)

05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
MGTA Magenta Therapeutics
$11.67 /

-0.16 (-1.35%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.16 /

+0.045 (+1.44%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$13.01 /

-1.04 (-7.40%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$126.52 /

+1.5 (+1.20%)

05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
EPZM Epizyme
$8.47 /

+0.1 (+1.19%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$86.23 /

+1.45 (+1.71%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.24 /

+0.04 (+0.77%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$7.11 /

-0.48 (-6.32%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/20/21 Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
SGEN Seagen
$155.59 /

+0.89 (+0.58%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.83 /

-0.185 (-2.05%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.43 /

-0.475 (-1.16%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$347.81 /

-1.53 (-0.44%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$58.87 /

+0.79 (+1.36%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$59.04 /

-1.07 (-1.78%)

04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
03/01/21 JPMorgan
JPMorgan downgrades Agios on lack of 'game-changing catalysts'
FMTX Forma Therapeutics
$29.18 /

-1.795 (-5.80%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.31 /

-0.36 (-0.70%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.99 /

-0.01 (-0.17%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$179.22 /

+2.59 (+1.47%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$126.52 /

+1.5 (+1.20%)

VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

SGEN Seagen
$155.59 /

+0.89 (+0.58%)

RIGL Rigel Pharmaceuticals
$4.09 /

+0.11 (+2.76%)

QURE uniQure
$36.57 /

-0.37 (-1.00%)

ORTX Orchard Therapeutics
$5.24 /

+0.04 (+0.77%)

MGTA Magenta Therapeutics
$11.67 /

-0.16 (-1.35%)

MEIP MEI Pharma
$3.16 /

+0.045 (+1.44%)

MBIO Mustang Bio
$3.76 /

+0.005 (+0.13%)

KROS Keros Therapeutics
$51.31 /

-0.36 (-0.70%)

JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

IMRA Imara
$8.83 /

-0.185 (-2.05%)

GBT Global Blood Therapeutics
$40.43 /

-0.475 (-1.16%)

FMTX Forma Therapeutics
$29.18 /

-1.795 (-5.80%)

EQ Equillium
$7.11 /

-0.48 (-6.32%)

EPZM Epizyme
$8.47 /

+0.1 (+1.19%)

CRIS Curis
$13.01 /

-1.04 (-7.40%)

BGNE BeiGene
$347.81 /

-1.53 (-0.44%)

APTO Aptose Biosciences
$5.35 /

-0.14 (-2.55%)

APLS Apellis
$58.87 /

+0.79 (+1.36%)

ALXN Alexion
$179.22 /

+2.59 (+1.47%)

AGIO Agios Pharmaceuticals
$59.04 /

-1.07 (-1.78%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
  • 11
    Jun
VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

RIGL Rigel Pharmaceuticals
$4.09 /

+0.11 (+2.76%)

ORTX Orchard Therapeutics
$5.24 /

+0.04 (+0.77%)

JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

EPZM Epizyme
$8.47 /

+0.1 (+1.19%)

VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

SGEN Seagen
$155.59 /

+0.89 (+0.58%)

QURE uniQure
$36.57 /

-0.37 (-1.00%)

JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

IMRA Imara
$8.83 /

-0.185 (-2.05%)

GBT Global Blood Therapeutics
$40.43 /

-0.475 (-1.16%)

EQ Equillium
$7.11 /

-0.48 (-6.32%)

CRIS Curis
$13.01 /

-1.04 (-7.40%)

APTO Aptose Biosciences
$5.35 /

-0.14 (-2.55%)

APLS Apellis
$58.87 /

+0.79 (+1.36%)

ALXN Alexion
$179.22 /

+2.59 (+1.47%)

VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

FMTX Forma Therapeutics
$29.18 /

-1.795 (-5.80%)

EQ Equillium
$7.11 /

-0.48 (-6.32%)

CRIS Curis
$13.01 /

-1.04 (-7.40%)

APLS Apellis
$58.87 /

+0.79 (+1.36%)

ALXN Alexion
$179.22 /

+2.59 (+1.47%)

Conference/Events
European Hematology Association to hold virtual meeting » 12:08
06/09/21
06/09
12:08
06/09/21
12:08
AGIO

Agios Pharmaceuticals

$59.27 /

-0.84 (-1.40%)

, ALXN

Alexion

$178.40 /

+1.77 (+1.00%)

, APLS

Apellis

$58.69 /

+0.61 (+1.05%)

, APTO

Aptose Biosciences

$5.44 /

-0.055 (-1.00%)

, AZN

AstraZeneca

$57.21 /

+0.89 (+1.58%)

, BGNE

BeiGene

$350.00 /

+0.66 (+0.19%)

, CRIS

Curis

$13.47 /

-0.58 (-4.13%)

, CYAD

Celyad

$6.11 /

+0.11 (+1.83%)

, EPZM

Epizyme

$8.50 /

+0.13 (+1.55%)

, EQ

Equillium

$7.40 /

-0.19 (-2.50%)

, FMTX

Forma Therapeutics

$30.03 /

-0.94 (-3.04%)

, GBT

Global Blood Therapeutics

$40.53 /

-0.37 (-0.90%)

, IMRA

Imara

$9.20 /

+0.19 (+2.11%)

, INCY

Incyte

$84.85 /

+0.07 (+0.08%)

, JAZZ

Jazz Pharmaceuticals

$183.01 /

+3.98 (+2.22%)

, KROS

Keros Therapeutics

$51.77 /

+0.1 (+0.19%)

, MBIO

Mustang Bio

$3.77 /

+0.015 (+0.40%)

, MEIP

MEI Pharma

$3.17 /

+0.055 (+1.77%)

, MGTA

Magenta Therapeutics

$12.02 /

+0.19 (+1.61%)

, ORTX

Orchard Therapeutics

$5.30 /

+0.1 (+1.92%)

, QURE

uniQure

$37.15 /

+0.21 (+0.57%)

, RIGL

Rigel Pharmaceuticals

$4.11 /

+0.125 (+3.14%)

, SGEN

Seagen

$156.89 /

+2.19 (+1.42%)

, TGTX

TG Therapeutics

$37.19 /

+0.03 (+0.08%)

, VRTX

Vertex Pharmaceuticals

$211.91 /

+0.81 (+0.38%)

, XLRN

Acceleron

$126.11 /

+1.09 (+0.87%)

Virtual Meeting of EHA…

Virtual Meeting of EHA 2021 to be held on June 9-17.Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$126.11 /

+1.09 (+0.87%)

VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

SGEN Seagen
$156.89 /

+2.19 (+1.42%)

RIGL Rigel Pharmaceuticals
$4.11 /

+0.125 (+3.14%)

QURE uniQure
$37.15 /

+0.21 (+0.57%)

ORTX Orchard Therapeutics
$5.30 /

+0.1 (+1.92%)

MGTA Magenta Therapeutics
$12.02 /

+0.19 (+1.61%)

MEIP MEI Pharma
$3.17 /

+0.055 (+1.77%)

MBIO Mustang Bio
$3.77 /

+0.015 (+0.40%)

KROS Keros Therapeutics
$51.77 /

+0.1 (+0.19%)

JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

IMRA Imara
$9.20 /

+0.19 (+2.11%)

GBT Global Blood Therapeutics
$40.53 /

-0.37 (-0.90%)

FMTX Forma Therapeutics
$30.03 /

-0.94 (-3.04%)

EQ Equillium
$7.40 /

-0.19 (-2.50%)

EPZM Epizyme
$8.50 /

+0.13 (+1.55%)

CYAD Celyad
$6.11 /

+0.11 (+1.83%)

CRIS Curis
$13.47 /

-0.58 (-4.13%)

BGNE BeiGene
$350.00 /

+0.66 (+0.19%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

APTO Aptose Biosciences
$5.44 /

-0.055 (-1.00%)

APLS Apellis
$58.69 /

+0.61 (+1.05%)

ALXN Alexion
$178.40 /

+1.77 (+1.00%)

AGIO Agios Pharmaceuticals
$59.27 /

-0.84 (-1.40%)

AGIO Agios Pharmaceuticals
$59.27 /

-0.84 (-1.40%)

04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
03/01/21 JPMorgan
JPMorgan downgrades Agios on lack of 'game-changing catalysts'
ALXN Alexion
$178.40 /

+1.77 (+1.00%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
APLS Apellis
$58.69 /

+0.61 (+1.05%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
APTO Aptose Biosciences
$5.44 /

-0.055 (-1.00%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
BGNE BeiGene
$350.00 /

+0.66 (+0.19%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
CRIS Curis
$13.47 /

-0.58 (-4.13%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
CYAD Celyad
$6.11 /

+0.11 (+1.83%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
EPZM Epizyme
$8.50 /

+0.13 (+1.55%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
EQ Equillium
$7.40 /

-0.19 (-2.50%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
FMTX Forma Therapeutics
$30.03 /

-0.94 (-3.04%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
GBT Global Blood Therapeutics
$40.53 /

-0.37 (-0.90%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
IMRA Imara
$9.20 /

+0.19 (+2.11%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
INCY Incyte
$84.85 /

+0.07 (+0.08%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
KROS Keros Therapeutics
$51.77 /

+0.1 (+0.19%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
MBIO Mustang Bio
$3.77 /

+0.015 (+0.40%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
MEIP MEI Pharma
$3.17 /

+0.055 (+1.77%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
MGTA Magenta Therapeutics
$12.02 /

+0.19 (+1.61%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
ORTX Orchard Therapeutics
$5.30 /

+0.1 (+1.92%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
QURE uniQure
$37.15 /

+0.21 (+0.57%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.11 /

+0.125 (+3.14%)

04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
SGEN Seagen
$156.89 /

+2.19 (+1.42%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/20/21 Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
XLRN Acceleron
$126.11 /

+1.09 (+0.87%)

05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
XLRN Acceleron
$126.11 /

+1.09 (+0.87%)

VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

SGEN Seagen
$156.89 /

+2.19 (+1.42%)

RIGL Rigel Pharmaceuticals
$4.11 /

+0.125 (+3.14%)

QURE uniQure
$37.15 /

+0.21 (+0.57%)

ORTX Orchard Therapeutics
$5.30 /

+0.1 (+1.92%)

MGTA Magenta Therapeutics
$12.02 /

+0.19 (+1.61%)

MEIP MEI Pharma
$3.17 /

+0.055 (+1.77%)

MBIO Mustang Bio
$3.77 /

+0.015 (+0.40%)

KROS Keros Therapeutics
$51.77 /

+0.1 (+0.19%)

JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

IMRA Imara
$9.20 /

+0.19 (+2.11%)

GBT Global Blood Therapeutics
$40.53 /

-0.37 (-0.90%)

FMTX Forma Therapeutics
$30.03 /

-0.94 (-3.04%)

EQ Equillium
$7.40 /

-0.19 (-2.50%)

EPZM Epizyme
$8.50 /

+0.13 (+1.55%)

CRIS Curis
$13.47 /

-0.58 (-4.13%)

BGNE BeiGene
$350.00 /

+0.66 (+0.19%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

APTO Aptose Biosciences
$5.44 /

-0.055 (-1.00%)

APLS Apellis
$58.69 /

+0.61 (+1.05%)

ALXN Alexion
$178.40 /

+1.77 (+1.00%)

AGIO Agios Pharmaceuticals
$59.27 /

-0.84 (-1.40%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
  • 11
    Jun
VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

RIGL Rigel Pharmaceuticals
$4.11 /

+0.125 (+3.14%)

ORTX Orchard Therapeutics
$5.30 /

+0.1 (+1.92%)

JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

EPZM Epizyme
$8.50 /

+0.13 (+1.55%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

SGEN Seagen
$156.89 /

+2.19 (+1.42%)

QURE uniQure
$37.15 /

+0.21 (+0.57%)

JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

IMRA Imara
$9.20 /

+0.19 (+2.11%)

GBT Global Blood Therapeutics
$40.53 /

-0.37 (-0.90%)

EQ Equillium
$7.40 /

-0.19 (-2.50%)

CRIS Curis
$13.47 /

-0.58 (-4.13%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

APTO Aptose Biosciences
$5.44 /

-0.055 (-1.00%)

APLS Apellis
$58.69 /

+0.61 (+1.05%)

ALXN Alexion
$178.40 /

+1.77 (+1.00%)

VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

FMTX Forma Therapeutics
$30.03 /

-0.94 (-3.04%)

EQ Equillium
$7.40 /

-0.19 (-2.50%)

CRIS Curis
$13.47 /

-0.58 (-4.13%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

APLS Apellis
$58.69 /

+0.61 (+1.05%)

ALXN Alexion
$178.40 /

+1.77 (+1.00%)

Conference/Events
European Hematology Association to hold virtual meeting » 10:55
06/09/21
06/09
10:55
06/09/21
10:55
APTO

Aptose Biosciences

$5.52 /

+0.03 (+0.55%)

, MBIO

Mustang Bio

$3.81 /

+0.055 (+1.46%)

, QURE

uniQure

$37.10 /

+0.16 (+0.43%)

, RIGL

Rigel Pharmaceuticals

$4.10 /

+0.12